New Drug To Fight Against Localized High-Risk Prostate Tumors
Men with prostate cancer could significantly benefit from a recently approved hormone-depleting drug, according to results from a phase II clinical trial. The drug - abiraterone acetate (Zytiga(R)) - can help eliminate or almost eliminate tumors in many prostate cancer patients whose cancer has not yet metastasized. The study, conducted by researchers at Dana-Farber Cancer Institute in collaboration with other research centers, will be presented at the annual meeting of the American Society of Clinical Oncology (ASCO), June 1-5, in Chicago... (Source: Health News from Medical News Today)

West Africa: Domestic Violence Primary Threat to Women in Post-War Era
[IRC] Women in post-conflict West Africa continue to suffer violence at alarming levels and with shocking frequency, but the primary threat to their safety is not strangers or men with guns; it's their husbands, according to the International Rescue Committee. (Source: AllAfrica News: Health and Medicine)